Alfentanil pharmacokinetics in preterm infants.

Por Marlow, N, Weindling, A M, Van Peer, A, Heykants, J
Publicado em 1990

Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease

Por Preechagoon, Y, Charles, B, Piotrovskij, V, Donovan, T, Van Peer, A
Publicado em 1999

Itraconazole pharmacokinetics in patients with renal dysfunction.

Por Boelaert, J, Schurgers, M, Matthys, E, Daneels, R, van Peer, A, De Beule, K, Woestenborghs, R, Heykants, J
Publicado em 1988

Ketanserin pharmacokinetics in patients with renal failure.

Por Barendregt, J N, Van Peer, A, Van Der Hoeven, J G, Van Oene, J C, Tjandra, Y I
Publicado em 1990

Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation

Por Mouton, J. W., van Peer, A., de Beule, K., Van Vliet, A., Donnelly, J. P., Soons, P. A.
Publicado em 2006

Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.

Por Vandewoude, K, Vogelaers, D, Decruyenaere, J, Jaqmin, P, De Beule, K, Van Peer, A, Woestenborghs, R, Groen, K, Colardyn, F
Publicado em 1997

Population analysis of the non linear red blood cell partitioning and the concentration-effect relationship of draflazine following various infusion rates

Por Snoeck, E., Piotrovskij, V., Jacqmin, P., Van Peer, A., Danhof, M., Ver Donck, K., Woestenborghs, R., Van Belle, H., Van Bortel, L., Van Gool, R., Dupont, A. G., Heykants, J.
Publicado em 1997